Even small doses of opioids increase risk of road crashes, research finds

Drivers who have taken even a small dose of opioid painkillers have an increased risk of being injured in a car accident, a new study has found.

Among adult drivers prescribed opioids, a daily dose exceeding only 20 mg morphine (or equivalent) was associated with between a 21 per cent and 42 per cent increased risk of road trauma requiring a visit to an emergency department, the study found.

The study, published today in the journal JAMA Internal Medicine, was lead by Tara Gomes, a scientist at the Institute for Clinical Evaluative Studies. Gomes recently joined the Li Ka Shing Knowledge Institute of St. Michael's Hospital.

Gomes said it was the first study of its kind to demonstrate a relationship between the dose of opioid analgesics and risk of road trauma.

The study examined 549,878 patients ages 18 to 64 who received at least one publicly funded prescription for an opioid between April 1, 2003, and March 31, 2011, in Ontario. Opioids are drugs such as morphine, codeine or used to relieve moderate to severe pain.

Road trauma and the toxic effects of are two of the leading causes of in North America.

"Among drivers prescribed opioids, a significant relationship exists between the dose of opioid prescribed and risk of road trauma," said Gomes.

High opioid doses (between 100-199 mg of morphine or equivalent) were associated with a 42 per cent increased risk of road trauma relative to low doses.

"Injury and death resulting from have significant public health and ," Gomes said. "These findings could have important implications for clinicians when escalating patients to high opioid doses, and to policy makers tasked with educating the public on the potential risks of opioid medications."

Clinical guidelines recommend about 180-200 mg of or the equivalent as "upper dose thresholds."

Gomes is also the lead scientist for the Ontario Drug Policy Research Network, a province-wide network of researchers who provide timely, high-quality advice for decision-makers.

Related Stories

Opioid abuse linked to mood and anxiety disorders

Dec 13, 2011

Individuals suffering from mood and anxiety disorders such as bipolar, panic disorder and major depressive disorder may be more likely to abuse opioids, according to a new study led by researchers from the Johns Hopkins Bloomberg ...

New guidelines for prescribing opioid pain drugs published

Feb 10, 2009

A prestigious panel of pain-management experts representing the American Pain Society (APS) www.ampainsoc.org and the American Academy of Pain Medicine (AAPM) has published the first comprehensive clinical practice guidel ...

Recommended for you

Mirabegron for overactive bladder: Added benefit not proven

14 hours ago

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products ...

Novartis Japan admits concealing drug side effects

Sep 01, 2014

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

User comments